1Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; and.
2Department of Neurological Surgery, University of Southern California, Los Angeles, California.
J Neurosurg. 2018 May;128(5):1388-1395. doi: 10.3171/2016.12.JNS162168. Epub 2017 Jul 7.
OBJECTIVE The purpose of this study was to describe a method of resecting temporal gliomas through a keyhole lobectomy and to share the results of using this technique. METHODS The authors performed a retrospective review of data obtained in all patients in whom the senior author performed resection of temporal gliomas between 2012 and 2015. The authors describe their technique for resecting dominant and nondominant gliomas, using both awake and asleep keyhole craniotomy techniques. RESULTS Fifty-two patients were included in the study. Twenty-six patients (50%) had not received prior surgery. Seventeen patients (33%) were diagnosed with WHO Grade II/III tumors, and 35 patients (67%) were diagnosed with a glioblastoma. Thirty tumors were left sided (58%). Thirty procedures (58%) were performed while the patient was awake. The median extent of resection was 95%, and at least 90% of the tumor was resected in 35 cases (67%). Five of 49 patients (10%) with clinical follow-up experienced permanent deficits, including 3 patients (6%) with hydrocephalus requiring placement of a ventriculoperitoneal shunt and 2 patients (4%) with weakness. Three patients experienced early postoperative anomia, but no patients had a new speech deficit at clinical follow-up. CONCLUSIONS The authors provide their experience using a keyhole lobectomy for resecting temporal gliomas. Their data demonstrate the feasibility of using less invasive techniques to safely and aggressively treat these tumors.
本研究旨在描述通过锁孔脑叶切除术切除颞叶胶质瘤的方法,并分享使用该技术的结果。
作者对 2012 年至 2015 年间,高级作者行颞叶胶质瘤切除术的所有患者的数据进行了回顾性分析。作者描述了使用清醒和睡眠锁孔开颅技术切除优势半球和非优势半球胶质瘤的技术。
研究共纳入 52 例患者。26 例(50%)患者未接受过手术。17 例(33%)患者诊断为 WHO Ⅱ/Ⅲ级肿瘤,35 例(67%)患者诊断为胶质母细胞瘤。30 例肿瘤位于左侧(58%)。30 例手术(58%)在患者清醒时进行。肿瘤切除程度的中位数为 95%,35 例(67%)至少切除了 90%的肿瘤。49 例有临床随访的患者中有 5 例(10%)出现永久性缺陷,包括 3 例(6%)因脑积水需要放置脑室腹腔分流管和 2 例(4%)因乏力。3 例患者术后早期出现构音障碍,但无患者在临床随访时有新的言语障碍。
作者提供了使用锁孔脑叶切除术切除颞叶胶质瘤的经验。他们的数据表明,使用微创技术安全且积极地治疗这些肿瘤是可行的。